sigma-1 receptor modulator

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all sigma-1 receptor modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting sigma-1 receptor, Sigma-1 receptor, Muscarinic acetylcholine receptor.

Targets

sigma-1 receptor · Sigma-1 receptor, Muscarinic acetylcholine receptor

Phase 3 pipeline (1)

GP40081 · Geropharm · Neurology
GP40081 is a small molecule drug that targets the sigma-1 receptor.

Phase 2 pipeline (1)

ANAVEX2-73 Intravenous · Anavex Life Sciences Corp. · Neurology
ANAVEX2-73 is a small molecule that modulates sigma-1 receptors and muscarinic acetylcholine receptors, which may have neuroprotective effects.